Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02998567
Brief Title: Combination Study of Guadecitabine and Pembrolizumab. (HyPeR)

First Submitted : November 2, 2016
First Submitted that Met QC Criteria : December 16, 2016
First Posted : December 20, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 16, 2020
Last Update Posted : November 17, 2020